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Effects of high glucose on the production of heparan sulfate proteogly-
can by mesangial and epithelial cells. Changes in heparan sulfate metab-
olism may be important in the pathogcnesis of diabetic nephropathy.
Recent studies performed on renal biopsies from patients with diabetic
nephropathy revealed a decrease in heparan sulfate glycosaminoglycan
staining in the glomerular basement membrane without changes in
staining for heparan sulfate proteoglycan-core protein. To understand this
phenomenon at the cellular level, we investigated the effect of high glucose
conditions on the synthesis of heparan sulfate proteoglycan by glomerular
cells in vitro. Human adult mcsangial and glomerular visceral epithelial
cells were cultured under normal (5 mM) and high glucose (25 mM)
conditions. Immunofluorescence performed on cells cultured in 25 mM
glucose confirmed and extended the in vivo histological observations.
Using metabolic labeling we observed an altered proteoglycan production
under high glucose conditions, with predominantly a decrease in heparan
sulfate compared to dermatan sulfate or chondroitin sulfate proteoglycan.
N-sulfation analysis of heparan sulfate protcoglycan produced under high
glucose conditions revealed less di- and tetrasaccharides compared to
larger oligosaccharides, indicating an altered sulfation pattern. Further-
more, with quantification of glomerular basement membrane heparan
sulfate by ELISA, a significant decrease was observed when mesangial and
visceral epithelial cells were cultured in high glucose conditions. We
conclude that high glucose concentration induces a significant alteration
of heparan sulfate production by mesangial cells and visceral epithelial
cells. Changes in sulfation and changes in absolute quantities arc both
observed and may explain the earlier in vivo observations. These changes
may be of importance for the altered integrity of the glomerular charge-
dependent filtration barrier and growth-factor matrix interactions in
diabetic nephropathy.
Diabetic nephropathy (DN) affects approximately 30 to 40% of
patients with type I diabetes mellitus [1, 2]. Histological hallmarks
of this complication include glomerular basement membrane
(GBM) thickening, mesangial expansion and sclerosis due to
increased production of extracellular matrix (ECM). This increase
in ECM is mainly due to an increased amount of collagen type IV,
laminin and fibronectin, while heparan sulfate proteoglycan
(HSPG) is relatively or absolutely decreased [31. A decrease in
negatively charged molecules within the glomerular basement
membrane is thought to be responsible for the albuminuria seen
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in diabetic nephropathy [4]. HSPGs are believed to be important
in this respect, since they consist of sulfate groups distributed
along glycosaminoglycan side chains and these may, among other
molecules, maintain the negative charge in the GBM [5—7]. HSPG
is also an inhibitor of mesangial proliferation, an effect which is
dependent on the charge distribution along the glycosaminoglycan
(GAG) chains of HSPG [8—10]. Vernier et al [4] showed a
reduction of HS associated anionic sites in the lamina rara externa
and interna of the GBM in advanced diabetic nephropathy by
ultrastructural analysis with cuprolinic blue staining. Removal of
HSPG by digestion with heparitinase leads to increased perme-
ability for both ferritin [6] and albumin [5], and injection of
antibodies to HS leads to an acute selective proteinuria in rats
[ii]. Recent immunofluorescence studies by our group on renal
biopsies from patients with DN revealed a decrease in HS staining
intensity in the GBM without changes in HSPG-core protein
staining [3]. Several studies in humans [12, 13] and models of
experimental diabetes [14—171 have revealed changes in, or a
decrease of, HS production in glomeruli. However, it still remains
unclear whether these changes of I-IS are absolute or relative.
Furthermore, it is unknown whether changes concerning the
glycosaminoglycan part of the molecule or its sulfation occur.
Since the glomeruli in the kidney consist largely of three cell types,
that is, endothelial, epithelial, and mesangial cells, cultures of
these cells could provide for a useful tool to investigate the
proteoglycan production under high glucose conditions in vitro.
We have recently shown that glomerular visceral epithelial cells
(GVEC) and mesangial cells (MC) each have their characteristic
pattern of proteoglycan production and differ in heparan sulfate
quantity [18]. Especially, GVEC are thought to be important in
this respect, since these cells are most likely the major source of
proteoglycans incorporated in the lamina externa of the glomer-
ular basement membrane [19].
We hypothesize that high glucose induces changes in HS
production, that could differ between different cell types within
the glomerulus. Therefore, we cultured GVEC and MC from
human adult kidneys and investigated their proteoglycan produc-
tion under normal and high glucose conditions. These studies
were performed using immunofluorescence and metabolic label-
ing of the cells with both Na235SO4 and 3H-glucosamine or
Na235SO4 and 3H-leucine, followed by extensive purification
steps. Qualitative HS alterations (N-sulfation) were assessed by
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analyzing G-25 gel filtration profiles after HNO2 (pH 1.5) treat-
ment. Furthermore, an inhibition ELISA using monoclonal anti-
bodies directed against GBM HS was used to measure quantita-
tive differences in HS production.
Methods
Cell culture
MC and GVEC were cultured from glomeruli obtained from
normal adult human kidneys that could not be used for transplan-
tation because of anatomical reasons. Methods used to culture
MC and GVEC have been published previously [18, 20, 21]. The
cells were characterized by their morphology and characteristic
immunofluorescence staining. In brief, MC were subcultured from
"hillocks," usually appearing after three weeks of outgrowth of
the glomeruli, in 24 well plates (Greiner, Frickenhausen, Ger-
many) in DMEM supplemented with 10% heat-inactivated fetal
calf serum (z FCS; Hyclone Laboratories Inc., Logan, UT, USA),
trypsinized, and seeded into T 25 or T 75 flasks. GVEC were
passaged immediately after outgrowing from the glomeruli (one
week) using PBS-20 mri EDTA into a T 25 or T 75 flask and
grown in DMEM with 5% FCS. Characterization of MC was
done on the basis of: (a) their cell morphology (multilayer, spindle
shaped); (b) uniform fluorescence with FITC-phalloidin for actin
and positive staining with monoclonal antibodies against vimen-
tin; (c) absence of staining using monoclonal antibodies TN9,
TN1 0 [22] and anti-von Willebrand factor, anti-cytokeratin and
anti-desmin. The monoclonal antibodies TN9 and TN1O specifi-
cally recognize proximal tubular epithelial cells and GVEC [22],
respectively, and were a gift of Drs. G. Muller and M. Nesper
(Medizinische Klinik, Tubingen, Germany). Characterization of
GVEC was done on the basis of: (a) their cell morphology
(confluent monolayer of polygonal cells); (b) positive staining with
monoclonal antibodies TN1O, anti-cytokeratin (RGE3) (Eurodi-
agnostics, Apeldoorn, The Netherlands) and anti-CALLA (Dako-
patt, Denmark); (c) absence of staining using monoclonal antibodies
TN9, anti-von Willebrand factor and anti-desmin. Experiments
were performed in "normal" (5 mivi = DMEM + 0.5% z FCS)
glucose and "high" glucose concentrations (25 mrvi = DMEM +
0.5% FCS + 20 mrvt D-glucose). Glucose concentrations were
checked using a glucose analyzer 2 (Beckman, USA) before and
after each experiment. As an osmotic control we used an L-
glucose (DMEM + 0.5% z FCS + 20 mM L-glucose) containing
medium. No insulin was added to either control or high glucose
media. In addition, we measured the insulin concentration (by
Radioimmunoassay, Medgenix, Brussels, Belgium; detection limit
3 mU/liter; coefficient of variation at different levels below 6%) in
both control and high glucose media containing 0.5 or 2.0%
FCS, and did not find detectable levels of insulin.
Immunofluorescence
Cells were grown on sterile glass coverslips (10,000 cells/well) in
DMEM containing 10% FCS. After 24 hours the cells were
starved in DMEM containing 0.5% z FCS for 24 hours. Subse-
quently, cells were grown for three days in DMEM with 0.5%
FCS alone (5 m glucose), 25 m glucose, or 25 mrvi L-glucose.
The cells were washed three times with phosphate buffered saline
(PBS), fixed in acetone for five minutes at 0°C, air-dried, and
immunofluorescent double staining was performed by incubating
with anti-HS monoclonal antibodies (JM 403) [11] and anti-HSPG
core (B31) polyclonal antibodies [231 for 30 minutes. After
extensive washing with PBS, the cells were incubated with tetra-
methylrhodamine isothiocyanate (TRITC)-conjugated rabbit
anti-goat IgG (RAG IgG-TRITC) (Nordic) followed by fluores-
cein isothiocyanate (FITC)-conjugated goat anti-mouse 1gM
(GAM IgM-FITC) for 30 minutes in the dark. GAM IgM-FITC
and RAG IgG-TRITC were used as controls. After washing three
times with PBS, the slides were mounted in 1,4 diazobicyclo(2, 2,
2)octane-glycerol (DABCO-glycerol) and assessed for fluores-
cence at 340 to 380 nm (FITC) or 560 nm (TRITC) and
photographed through a Leitz microscope (Wetzlar, Germany).
The slides were examined and scored without knowledge of the
sample origin by two independent observers. Furthermore, inten-
sity of staining was scored on a semiquantitative scale using the
exposure time (in seconds) of the camera as measure.
Metabolic labeling
MC and GVEC were cultured in T 75 flasks until confluence
and cultured overnight with DMEM supplemented with 2%
FCS. Metabolic labeling of cells in media supplemented with a
dose response of z FCS revealed that a 2% concentration induced
maximal incorporation of the label (data not shown). Media were
replaced by sulfate free DMEM or sulfate and leucine free
DMEM with 2% FCS and labeled for 24 hours at 37°C using
100 J.LCi/ml Na235504 (carrier-free; New England Nuclear, Bos-
ton, MA, USA) and 25 Ci/ml 3H glucosamine or 50 tCi/ml
DL-(4, 5)-3H leucine (Amersham International, UK). Cell label-
ing was performed in different culture conditions: (a) 5 mi
glucose; (b) 25 m glucose; and (c) 25 mM L-glucose (osmotic
control). After 24 hours the cell media were separated from the
cells. The cells were washed three times with cold PBS and these
washes were added to the cell media fraction. Cells were scraped
into an extraction buffer using 4 M guanidine HCI at 4°C with the
following protease inhibitor cocktail: 10 mt EDTA and 5 ifiM
phenylmethyl sulfonyl fluoride (PMSF), 2 mtvi benzamidine, 50
mM €-aminocaproic acid, 0.5 U/mI aprotinin and 5 mM iodoacet-
amide (all from Sigma, St. Louis, MO, USA). Both the cell media
and cell extracts were extensively dialyzed against 0.5 M sodium
acetate pH 5.8 with protease inhibitor cocktail at 4°C. The
fractions were finally dialyzed against DEAE buffer containing 6 M
urea, 50 mM Tris, 0.2% chaps with protease inhibitors cocktail, pH
7.0, and first separated on a 5 ml DEAE anion exchange chroma-
tography column. For the second and final purification the labeled
material was separated using HPLC with a DEAE anion exchange
75 X 7.5 mm Bio-Gel TSK DEAE-5PW HPLC column (Biorad,
Richmond, CA, USA). The bound material was eluted with an
increasing NaCI gradient in DEAE buffer (0.1 to 1.0 M), at a flow
rate of 1 ml/min, with 1.0 ml fractions collected. The conductivity
of each fraction was measured using a CDM3 radiometer conduc-
tivity meter (Copenhagen, Denmark) and the 35s and 3H radio-
activity were measured by adding aliquots of the fractions to a
fluorophore Ultima Gold (Packard). The separation protocol
resulted in different proteoglycan peaks. These peaks were dia-
lyzed against distilled water, freeze dried and stored at —20°C
until use. Characterization of the different macromolecules was
performed as described previously [181. Briefly, each of the pooled
fractions were treated with 0.75 M NaOH and 20 m sodium
borohydride (NaBH4) (alkaline /3 elimination) for one hour at
72°C [241 followed by separation on a G50 size separation column
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run in 0.5 M sodium acetate buffer containing 0.2% chaps and
protease inhibitor cocktail, pH 7.0. The G50 column was presatu-
rated with 1 mg/mi heparin and 10 mg/mI bovine serum albumin
(BSA). The void volume was tested for its sensitivity to chon-
droitinase ABC (Ch-ABC; 2.5 mU), chondroitinase AC (Ch-AC;
2.5 mU) and nitrous acid pH 1.5 (HNO2) [25—27]. Identification
of the 35S13H glycosaminoglycans was determined by the following
criteria: (a) molecules with sensitivity to HNO2 pH 1.5 without
scnsitivity to Ch-ABC or Ch-AC are designated as heparan
sulfate; (b) molecules with sensitivity to Ch-ABC without sensi-
tivity to Ch-AC were designated as dermatan sulfate; and (c)
molccules equally sensitive to both Ch-ABC and Ch-AC were
referred to as chondroitin sulfate.
Distribution of oligosaccharides formed by nitrous acid cleavage
HSPG isolated from the cell media and cell extracts of GVEC
were treated with papain (1 mg/ml) for 18 hours at 55°C, and
subsequently heat inactivated at 100°C [281. The material was
centrifuged (3000 rpm) to spin down the papain. The supernatant
was cleaved with HNO2 at pH 1.5, and separated into di-, tetra-,
and higher oligosaccharides by gel filtration on a G25 sephadex
size separation column (0.95 X 100 cm) in 0.5 M NH4HCO3 (2
ml/hr) [29].
Heparan sulfate ELISA
HSPG were detected using an inhibition ELISA with mouse
monoclonal antibodies that specifically recognize GBM 1-IS [30].
Cells were cultured in 12 well plates and starved overnight using
DMEM with 0.5% A FCS. Experiments were performed in 0.5%
A FCS to induce quiescence of the cells and to minimize the
background determination in ELISA. Before and after each
experiment cell numbers were determined in triplicate using a
Coulter Counter (Coulter Electronics, Mijdrecht, The Nether-
lands). Cells were cultured for three days in (a) DMEM with 0.5%
A FCS alone (5 mt glucose), (b) 25 mM glucose or (c) 25 mM
L-glucose (osmotic control). HS production of four different cell
lines was measured in triplicate and expressed as g/106 cells/72
hours. Since MC and GVEC produce the complement component
factor H, this molecule was used as a control for "normal protein"
synthesis using a sandwich ELISA [31]. Cell death was determined
by quantification of the lactate dehydrogenase (LDH) levels in the
cell media.
Statistical analysis
The data of control and experimental groups were expressed as
means so. For statistical analysis we used the Student's t-test for
unpaired samples, and a P value <0.05 was considered significant.
Results
Immunofluorescence
Immunofluorescence performed on normal cultured MC re-
sulted in a primarily intracellular staining with an filamentous
pattern using both anti-HS and anti-HSPG antibodies. This
staining could be inhibited by addition of HS. Intensity of HS
staining decreased significantly (P < 0.002) (exposure time (in
seconds) 1.4 0.01 to 3.3 1.1) after culturing cells in 25 mM
glucose, when compared to cells cultured in 5 m glucose or 25
mM L-glucose (Fig. 1 A, C). In contrast, no difference of staining
intensity was observed in 5 m glucose and 25 m glucose treated
cells using anti-HSPG core antibodies (exposure time 9.6 0.6 to
10.6 1.3; Fig. 1 B, D). GVEC showed predominately intracel-
lular staining for both antibodies. The intensity of HS staining
after culturing these cells under high glucose (25 m glucose)
conditions was reduced (P < 0.02) (exposure time 45.5 4.2 to
89.6 10.5) when compared to normal (5 m glucose) conditions
(Fig. 2 A, C). Staining of the cells grown in 25 mM L-glucose did
not result in a change of intensity. Also, staining of cells with
anti-HSPG core antibodies did not show any difference irrespec-
tive of the glucose concentration (exposure time 48.6 1.9 to 41.5
3.4; Fig. 2 B, D)
Metabolic labeling
MC and GVEC were labeled as described in Methods. The cell
media and cell extracts were harvested and the proteoglycans
were purified as described. The chemical characterization of the
different proteoglycans obtained, has been described previously
[18]. Briefly, cell media of MC (Fig. 3 A-C) contained one
glycoprotein and the proteoglycans HS (I) (51% of the total
35S-proteoglycan production) and dermatan sulfate (II) (49%).
The cell extracts of these cells consisted of (I) HS (58%) and
dermatan sulfate (42%) (II) (Fig. 3 D-F). The cell media of
GVEC (Fig. 4 A,B) consisted of three glycoproteins and the
proteoglycans HS (I) (62%) and a hybrid molecule of both
chondroitin sulfate and HS (38%)(I1). The cell extracts contained
the proteoglycans HS (I) (79%) and chondroitin sulfate (I1)(21%)
(Fig. 4 C,D). The nature of HSPG produced by GVEC and MC
was studied in detail [181 and are important for the interpretation
of this study. In brief, by SDS-PAGE we found a 400 kD core
protein of HSPG isolated from both the cell media and cell
extracts of GVEC. This molecular weight of 400 kD correlated
well with the molecular weight of perlecan, the large basement
membrane HSPG. Furthermore, expression of this type of HSPG
was found using RT-PCR. Peak fractions containing HSPG (as
documented by sensitivity to HNO2 treatment) reacted positive in
an ELISA system using antibodies recognizing perlecan. Finally,
HSPG isolated from both the cell media and cell extracts of
GVEC and MC were subjected to size separation chromatography
using a HR 200 sephadex column (HPLC). HSPG isolated from
GVEC and MC eluted at a Kay of 0.047 and 0.058, respectively,
at which molecules with a molecular weight around 400 kD
normally elute.
Absolute differences in proteoglycan production cannot be
given with the methods used for isolation since we had to employ
two purification steps, first a 5 ml DEAE column and finally a
HPLC-DEAE column. The first purification gave variable recov-
eries. Therefore, we compared production of HS to other proteo-
glycans. This was done by determining the ratio of proteoglycan
production of HS (peak I) over other proteoglycans (peak II).
Culturing MC under high glucose conditions resulted in the
following changes:
(1) HPLC profiles of the cell media were altered (Fig. 3 A, B),
as reflected by decreased Na235SO4 ratios and 3H glucosamine
(peak I/TI). Mean ratios of three experiments showed a 2.2-fold
decrease for the Na235SO4 (1.1 0.3 to 0.5 0.1) and 2.3-fold
decrease for 3H glucosamine (1.3 0.3 to 0.6 0.1) ratios (Table
1).
(2) The HPLC profiles of the cell extracts changed (Fig. 3 D,
E). The mean Na235SO4 ratio (peak I/Il) did not change (1.4 0.1
+, E;f
Fig. 1. Immunofluorence pattern of mesangial
cells cultured under normal or high glucose
conditions. Cells were grown on sterile
coverslips, fixed with acetone and subsequently
stained with either anti-HS monoclonal
antibodies (a, control; c, 25 m glucose) or
with anti-HSPG-core polyclonal antibodies (b,
control; d, 25 mM glucose). GAM IgM-FITC
(e) and RAG IgG-TRITC (1) were used as
negative controls.
to 1.3 0.1 (N = 3), whereas the 3H glucosamine ratio (peak I/IT)
decreased 1.8-fold (1.2 0.1 to 0.7 0.2; Table 1).
When GVEC were cultured under high glucose conditions we
observed the following changes:
(1) HPLC profiles of the cell media were not altered (Fig. 4 A,
B). No significant changes were observed for the mean Na235SO4
(peak I/TI) ratios (1.7 0.3 to 1.5 0.2) and the 3H glucosamine
ratios (peak 1/11; 1.8 0.5 to 1.8 0.6; Table 2).
(2) Analysis of the cell extracts of these cells revealed an
alteration of the HPLC profile (Fig. 4 C, D). The three different
cell lines behaved differently in this respect since the Na235SO4
ratio changed from 3.7 to 0.7, 3.9 to 2.6 or 1.1 to 0.6, respectively
(Table 2). The 3H glucosamine (peak I/IT) ratios changed from 3.8
to 0.8, 3.9 to 2.8 and 1.1 to 0.6 in the three cell lines that were
tested.
To compare the effects of high glucose on changes in HS to
HSPG core protein synthesis, we metabolically labeled the cells
with Na235SO4 and 3H-leucine. Unfortunately, GVEC hardly
incorporated 3H-leucine in the proteoglycans they produced (data
not shown) as has been published previously [25]. Therefore, the
profiles obtained from these experiments are only depicted for
MC. Compared to controls, exposure of MC (Fig. 3C) to 25 mM
glucose resulted in a 1.4-fold decrease in ratio of 3H-leucine
HS/DS (peak I/Il) from 1.5 to 1.1. The cell extracts (Fig. 3F)
analysis revealed no change in 3H leucine HS/DS (peak I/Il) ratio
(1.1 to 1.1).
Distribution of oligosaccharides formed by nitrous acid cleavage
HS isolated from the cell media and cell extracts of GVEC
grown in 5 or 25 m glucose media were separated as described
in methods. Nitrous acid treatment at pH 1.5 separated HS in di-
(peak LII), tetra-(peak II) and larger (peak I) oligosaccharides
(Fig. 5). Peaks I, II and III were combined as shown in Figure 5
and analyzed for 3H glucosamine (Table 3). When no discernible
peak was obtained we calculated the cpm in the fraction which
eluted at the same Kay as the original peak fraction (represents
molecules with the same molecular weight).
Around 66% of the 3H labeled HS isolated from the cell media
of GVEC grown in 5 m glucose cleaved into di- and tetrasac-
charides, whereas 34% was either not cleaved or cleaved into
larger fragments. HS obtained from GVEC (cell media) grown
with 25 m glucose resulted in a different cleavage pattern that is,
di- and tetrasaccharides (51%) and larger fragments (49%).
Nitrous acid treatment of HS obtained from the cell extracts of
GVEC (5 mM) resulted in 55% di- and tetrasaccharides and 45%
of larger oligosaccharides. HS obtained from the extract of high
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Fig. 2. Immunofluorence pattern of glomerular
visceral epithelial cultured under normal or high
glucose conditions. Cells were grown on sterile
coverslips, fixed with acetone and subsequently
stained with either anti HS monoclonal
antibodies (a, control; c, 25 m glucose) and
with anti HSPCj-core polyclonal antibodies (b,
control; d, 25 mi glucose). GAM IgM-FITC
(e) and RAG lgG-TRITC (f) were used as
negative controls.
glucose treated cells resulted in the same distribution between
higher and di- and tetrasaccharides, However, the distribution
between di- and tetrasaccharides was altered. The percentage
disaccharides changed from 24 to 11% and the tetrasaccharides
increased from 31 to 43%.
Heparan sulfate ELISA
MC and GVEC synthesize de novo heparan sulfate, since
addition of cycloheximide blocks the production [18]. MC pro-
duced between 29.8 to 40.7 jxg/106 cells/72 hr (N = 4), whereas
GVEC produced between 216.7 and 282.3 LgI106 cells/72 hr (N =
4; Table 4). Both MC and GVEC produced less HS when cultured
in high glucose conditions. In the presence of increasing concen-
trations (5 to 25 mM) of glucose, MC produced significantly lower
amounts of heparan sulfate from 15 m glucose and onwards
(Fig. 7A). For GVEC we observed a significant decrease in HS
production when cultured in 10 m glucose and higher (Fig. 7B).
High glucose induced a two- to sixfold (P < 0.01) reduction in HS
production by MC (4 different cell lines; Table 4), whereas for
GVEC this decrease was twofold (P < 0.05; 3 different cell lines).
The decrease in HS production of GVEC was more variable since,
in one UVEC line we observed a much more pronounced
decrease in HS production (Table 4, Fig. 7B). L-glucose did not
have any effect on the HS synthesis (data not shown). No
differences in factor H production by MC [112.11 8.9 ngIlO6
cells/72 hr (5 mM) and 126.28 2.97 ng/106/72 hr; N = 3 (25 mM)]
or by visceral epithelial cells (20.10 4.96 ngIlO6 cells/72 hr and
22.14 3.31 ngIlO6 cells/72 hr; N = 3) cultured in "normal" and
"high glucose" conditions were observed. No detectable levels of
LDH were observed in both cell types cultured in the presence of
5 or 25 m glucose.
We attempted to measure HSPG core protein using an ELISA
with anti-HSPG core antibodies (JM 72 and B31) [30]. However,
even after improvement, this ELISA was not sensitive enough to
measure HSPG in the linear part of the standard curve of the
ELISA. Therefore, we cannot provide data about the HSPG core
production by GVEC and MC.
Discussion
In this study we analyzed whether high glucose concentrations
had an influence on proteoglycan production by cultured glomer-
ular cells. We focused primarily on HSPG production, since
previous studies have showed abnormal expression, content,
sulfation and/or matrix interaction of this type of proteoglycan in
the diabetic GBM [3, 4, 13—15, 32]. HSPG in the GBM seem to be
relevant for maintenance of the negative charge barrier, since
removal of the molecule by digestion with heparitinase leads to
increased permeability for both ferritin [6] and albumin [5]. Also
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injection of antibodies to HS leads acutely to a selective protein-
uria in rats [111. Furthermore, HSPG is known to be important in
the self assembly and organization of the matrix in the GBM and
mesangium. Reduction in the glomerular HSPG content may lead
to an increased synthesis of extracellular matrix and thickening of
the GBM [32].
Our data support the hypothesis that the diabetic milieu can
change renal HS metabolism since high glucose conditions in-
duced an altered HS production by both adult human MC and
GVEC in vitro. This phenomenon was found using three different
methods: immunofluorescence, metabolic labeling and quantifi-
cation by ELISA. Immunofluorescence clearly showed a de-
creased staining of HS, for both MC and OVEC when grown
under high glucose conditions, whereas staining for the HSPG
core protein remained unchanged. These results were consistent
with the in vivo histological observations in kidneys with diabetic
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Table 1. Influence of high glucose (25 mM) on the production of
heparan sulfate (HS) and dermatan sulfate (DS) by human mesangial
cells both excreted (media) and cell associated (extract)
5 mMa
HS/DS
Na235SO4
25 mrvta
HS/DS
3H glucosamine
5 mivi 25 mM
Media 1
2
3
0.9
1.0
1.4
05(11)
0.6
0.5
1.2
1.1
1.6
O6(10)'
0.7
0.5
Extract 1
2
3
1.5
1.3
1.5
1.1 (l1)
1.1
1.3
1.0
1.0
1.7
0.6 (11)
0.9
0.5
Results are expressed as HS/DS ratios as assessed by Na235SO4 and
3H-glucosamine labeling.
a Concentration of glucose in culture medium
b Ratios obtained after culture in L-glucose containing media
nephropathy [3, 32]. Using the same antibodies, a decreased GBM
HS staining was observed in biopsies from patients with overt
diabetic nephropathy, while the staining for HSPG core remained
unchanged. No differences in staining for HS or HSPG core were
observed when cells were cultured with 25 mrvt L-glucose instead
of 25 mM D-glucose. L-glucose is not taken up by cells, but does
create the same high osmotic environment. The (unchanged)
staining intensity was similar to that of cells grown in 5 mM
D-glucose, and indicates that the observed changes were not due
to an osmotic effect.
Table 2. Influence of high glucose (25 mM) on the production of
heparan sulfate (HS) and chondroitin sulfate (CS) by human
glomerular epithelial cells both excreted (media) and cell associated
(extract)
HS/HSCS
Na235SO4
HS/HSCS
3H glueosamine
5 mM 25mM5 mMa 25 mMa
Media 1
2
3
2.0 1.6
1.6 1.5
1.3 1.2 (l.3)b
HS/CS
Na235SO4
1.9 1.8
2.3 2.4
1.3 1.2 (1.1)"
HS/CS
3H glucosamine
Extract 1
2
3
3.7 0.7
3.9 2.6
1.1 0.6 (l.l)b
3.8 0.8
3.9 2.8
1.1 0.6 (i.3)b
Results are expressed as HS/CS ratios as assessed by Na235SO4 and
3H-glucosamine labeling.a Concentration of glucose in culture medium
h Ratios obtained after culture in L-glucose containing media
To further investigate the effects of high glucose on the HSPG
production compared to HS-GAG, we performed metabolic dual
labeling with Na235SO4 and 3H-glucosamine, to investigate the
effect of "high glucose" conditions on Na235SO4 compared to
3H-labeled glycosaminoglycan side chains, or with 35S-sulfate and
3H-leucine to compare 35S-labeled glycosaminoglycan side chains
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Fig. 4. HPLC-DEAE chromatography of Na235SO4 (A, C) and 3H-glucosamine (B, D) labeled macromolecules synthesized by human glomendar visceral
epithelial cells cultured under normal (—, 5 mM glucose) or high glucose (_, 25 mM conditions. The profiles of the incorporated 35S/3H
macromolecules from the cell media (A,B) and cell extracts (C,D) that were eluted with a NaCI gradient are shown. The salt gradient was expressed
in milliSiemens (...
., mS).
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.Size
3H GAG %total
Cell media Cell extract
class Peaka 5 25 5 25
Di- Iii 35 27 24 11
Tetra- II 31 24 31 43
Higher I 34 49 45 47
to the 3H-labeled core protein. After separation of the proteogly-
cans by DEAE-anion exchange chromatography, we calculated
the ratio of both Na235SO4 and 3H incorporation in HS/CSHS or
HS/CS for GVEC and HS/DS for MC. With this method we
observed no changes in HS secreted in the cell media by GVEC,
as compared to the hybrid molecule (CSHS) for the Na235SO4 or
3H glucosamine ratios. For MC we observed a decrease in both
HS/DS 3H glucosamine ratio and HS/DS Na235SO4 ratio and a
slight decrease in the 3H leucine ratio. For both cell types we
found decreased HS/DS and HS/CS 3H glucosamine ratios,
respectively, when analyzing the cell extracts. This overall de-
crease in ratio of HS compared to either DS or CS may indicate
either: (a) an absolute decrease in HS production without affect-
ing the DS or CS production; or (b) a decrease in HS and an
increase in DS or CS production; or (c) unchanged HS production
and increased DS or CS production. The decrease in 3H leucine
HS/DS ratio observed when analyzing the media of MC is difficult
to interpret since the HSPG-core protein staining by IF remained
unaltered. However, this apparent discrepancy can be explained
by the fact that polyclonal antibodies against HSPG core protein
predominantly stain the cells intracellularly. This observation is
therefore in agreement with the unchanged 3H leucine HSIDS
ratio in the cell extract, which contains both intracellular and
extracellular components. The unchanged Na235SO4 and de-
creased 3H glucosamine ratios observed when analyzing the cell
extracts of MC could indicate either an oversulfation of HS or
undersulfation of DS,
To quantitate the change in HS production by GVEC and MC
under high glucose conditions in vitro, we measured the HS
content in the cell media using a specific GBM H5 inhibition
Fig. 5. G25 sephadex fractionation of heparan
sulfate deamination products obtained from
glomerular visceral epithelial cells. Heparan
sulfate excreted in the cell media (A) and
isolated from the cell extracts (B) of GVEC
grown in 5 or 25 m glucose were treated with
nitrous acid pH 1.5. The products were
chromatographed on a 0.95 X 100 cm G25
sephadex column in 0.5 M NH4HCO3. Fractions
of 1 ml were collected and analyzed for 3H.
Fractions were pooled as indicated by the bars.
Fraction III represents the disaccharides, lithe
tetrasaccharides and I the larger
oligosaccharides.
Cell
line #
Heparan sulfate tgIl06 cells/72 hr
MC GVEC
5 M' 25 mM 5 mM 25 mM
1 38.9 2.7 18.7 2.8 282.3 88.3 124.3 28.4c
2 40.7 5.4 11.3 30b 276.4 43.9 123.0 708d
3 29.8 8.0 5.1 2.1 225.6 10.9 115.4 9.26
4 35.2 8.8 8.1 2.8a 216.7 38.0 e
ELISA [301. De novo synthesized HS by MC was significantly
decreased when cells were cultured in high glucose containing
media as compared to control media. This decrease was observed
in four different cell lines. For GVEC we observed a less
pronounced, but also significant reduction in HS synthesis, when
cells were grown in the presence of 25 m glucose as compared to
control media (5 m glucose). The observed effect was not due to
changes in cell numbers, since these did not differ significantly
between "normal" and "high" glucose conditions, and further-
more, all HS levels were corrected for cell number. There were no
differences in overall protein production as was shown using
"factor H" ELISA and viability of the cells (LDH release). A dose
response of glucose concentrations revealed a significant decrease
in HS production when MC or GVEC were cultured in 15 m or
10 m glucose, respectively. Metabolic labeling of GVEC dem-
onstrated that incorporation and excretion of proteoglycans can
differ between cell lines which became apparent when we analyzed
the cell extracts of these cells. The problem of metabolic labeling
lies in the isolation procedures necessary to obtain the different
proteoglycans. This makes estimates of quantities in absolute
terms rather unprecise. We therefore focused in the metabolic
studies on relative changes comparing HS with other glycosami-
noglycans. Changes in terms of absolute quantities were only
studied by HS ELISA, whereas metabolic labeling not only served
as a useful tool to identify the different proteoglycans indepen-
dently from immunological characterization studies, but also
allowed us to study (1) changes in HS production compared with
other proteoglycans produced and (2) ratios of sulfate and
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Table 3. Distribution of oligosaccharides formed by nitrous
acid cleavage
Table 4. Production of heparan sulfate in four different cell lines of
mesangial cells (MC) and visceral epithelial cells (GVEC), cultured
under normal (5 mM) or high glucose (25 mM) conditions
Heparan sulfate isolated from the cell media and cell extract of GVEC
were cleaved by nitrous acid pH 1.5. The obtained fragments were
separated by G25 gel filtration chromatography.
Figure 5
Heparan sulfate was measured in the cell media using the heparan
sulfate inhibition ELISA. HS concentration was measured in triplicate and
expressed in jgI106 cells/72 hr.
< 0.01, b P < 0.002, C P< 0.02, d P < 0.05, Cundetectable, glucose
concentration in medium
riLJ_I :
5 10
Concentrations of glucose, m
glucosamine incorporation [181. This last parameter is of interest,
since it has been shown that sulfation patterns of GAG side chains
may be of significance for the specific interactions of proteogly-
cans with growth factors [33—35].
Therefore we also studied the heterogeneity in N-sulfation of
the oligosaccharides in HS. HS molecules obtained from the cell
media and cell extracts of GVEC grown in 5 or 25 m glucose
were cleaved with nitrous acid pH 1.5. Nitrous acid at pH 1.5
specifically cleaves HS in G1cNSO3 residues. To illustrate the
underlying mechanisms, relevant chemical structures are given in
Figure 6. Disacccharides are obtained from regions of the polymer
chain with contiguous N-sulfated disaccharides units, and tet-
rasaccharides are obtained from regions containing HNO2-resis-
tant GlcNAc residues [36]. Peaks I, II and III were combined as
Fig. 6. The possible heterogeneity of sulfation
along the HS-GAG side chains. Molecules
depicted in A, B and C may all function as
building blocks of the side chain. N-sulfation as
outlined in A, B and C would result in di-,
tetra- or larger saccharides as shown in Figure
5 as fractions III, II, and I, respectively. R =
S03/H; Ri = 6 or more saccharide residues;
* either iduronic or glucuronic acid.
Fig. 7. The effect of increasing concentrations of
glucose on the pmduction of heparan sulfate !
(A) mesangial cells and (B) glomerular visceral
epithelial cells. MC and GVEC were cultured
15 20 25 with a dose response of glucose for three days,
cell media was harvested and assessed in the
heparan sulfate ELISA in triplicate.
shown in Figure 5 and analyzed for 3H glucosamine (Table 3). The
size distribution of oligosaccharides of HS obtained from GVEC
grown in 25 m glucose was different from those obtained from
GVEC grown in 5 m*t glucose. Therefore, we conclude that there
is an altered N-sulfation pattern of heparan sulfate produced by
GVEC under high glucose conditions.
The biosynthesis of HS is dependent on a variety of processes.
The initiating and rate-limiting steps of these processes are the
N-deacetylation and subsequently N-sulfation of N-acetylglu-
cosamine; thus, CS epimerization of D-glucuronic acid to iduronic
acid and the many 0-sulfation reactions cannot occur until
N-sulfation has been initiated [37]. The differences in N-sulfation
are compatible with the idea that high glucose induces a change in
N-deacetylase activity, a hypothesis which has also been suggested
*
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by others [38, 39]. Unger et a! [39] observed that hepatocytes from
streptozotocin-diabetic rats expressed less N-deacetylase activity
than control rats. Recent studies from Ishihara et a! [36] demon-
strated that heparan sulfate-N-deacetylaselN-sulfotransferase
(NSNdAc/NST) catalyzes both the N-deacetylation and N-sulfa-
tion of glucosamine residues in HS. The level of HS-NdAc/NST
expression is important in regulating the formation of large fully
N-sulfated, highly 0-sulfated domains in HS. These domains have
high affinity for basic fibroblast growth factor (bFGF) and changes
in these domains may therefore be important for cell growth and
matrix production. Our results are compatible with the hypothesis
that the HS produced under high glucose conditions might
interact differently with growth factors because of an altered
sulfation pattern.
So far, in vitro studies using metabolic labeling, revealed only
changes of total labeled proteoglycan production by human fetal
MC [40] or rat MC [41]. Studies utilizing metabolic labeling of
streptozotocin-induced diabetic rats [14] with Na235SO4 revealed
30 to 40% decreased incorporation into the glomerular extracel-
lular matrices when compared to control animals. Silbiger et a!
[41] investigated the total production of proteoglycans by rat MC
under normal and high glucose conditions and found no differ-
ences. However, these findings could be due to a relative decrease
in HS production and a relative increase in DS production, since
the production of the individual components was not studied. To
our knowledge, no data are available concerning the negative
charge of human GBM-HSPG from patients with diabetic ne-
phropathy or diabetes. In vivo evidence for an altered GAG
synthesis and normal rates of HSPG core protein were described
by our group [3, 32]. Data from experimental animals were
published by several authors. Klein, Brown and Oegema [42]
studied GBM-HSPG isolated from metabolically labeled glomer-
uli obtained from streptozotocin induced diabetic rats. This group
found less 35S-proteoglycans in diabetics compared to control. A
decrease of HSPG was only found in the rapidly metabolized pool
of HS. However, no changes were found in the hydrodynamic size
or charge of these molecules. Evidence for decreased synthesis of
basement membrane-specific proteoglycans in diabetes also came
from work of Rohrbach et a! [15] showing that less HSPG was
synthesized by BM-producing tumors (EHS) grown in diabetic
mice despite an unchanged protein synthesis. No data concerning
the negative charge was given. Finally, Cohen, Klepser and Wu
[43] found a decrease in sulfate to uronate ratio in HSPG isolated
from the GBM of streptozotocin induced diabetic rats, indicating
reduction in charge.
In conclusion, our results demonstrate that high glucose condi-
tions lead to alterations in HS production by human adult GVEC
and MC in that there is a decreased production and a changed
pattern of N-sulfation. These alterations may cause a decreased
concentration of an altered HSPG in the glomerulus and thus lead
to albuminuria (by a decreased charge barrier) and mesangial
expansion (by a decreased interaction with growth factors such as
FGF) observed in vivo in diabetic nephropathy.
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